Repurposing butoconazole as a GRP78 substrate-binding domain (SBD) inhibitor to induce endoplasmic reticulum stress–mediated apoptosis in triple-negative breast cancer
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Yaowen Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang 110001, China. Hauptthemen laut MEDLINE: Apoptosis, Endoplasmic Reticulum Stress, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Southwest Jiaotong University.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is aggressive with limited therapies and poor prognosis. Butoconazole, a clinical topical imidazole antifungal for vulvovaginal candidiasis, has not previously been investigated for TNBC treatment. Here, we repurposed butoconazole as a novel allosteric inhibitor of glucose-regulated protein 78 (GRP78) for TNBC treatment. It suppressed TNBC cell proliferation (IC50: 13.61 ± 1.07 μM for MDA-MB-231, 26.17 ± 1.17 μM for MDA-MB-468), inhibited migration, and induced apoptosis, resulting in 68.28% tumor growth inhibition in MDA-MB-231 xenograft mouse models without evident toxicity. Mechanistically, we combined RNA-seq and limited proteolysis-mass spectrometry (LiP-MS) to identify GRP78 as its potential target, validated by surface plasmon resonance (SPR), biolayer interferometry (BLI), cellular thermal shift assay (CETSA), drug-affinity-responsive target-stability (DARTS) assay and molecular dynamics simulations. Unlike existing GRP78 modulators, butoconazole allosterically attaches to the helical bundle at the distal tip of GRP78 substrate-binding domain α (SBD-α), rearranges its binding pocket and blocks GRP78 chaperone activity. This triggers endoplasmic reticulum (ER) stress, elevates the expression levels of ATF4 and CHOP and induces apoptosis. Rescue assays with 4-phenylbutyrate (4-PBA), ATF4/CHOP knockdown or GRP78 overexpression attenuated butoconazole's anti-tumor activity. Collectively, butoconazole suppresses TNBC through allosteric GRP78 inhibition to trigger ER stress-mediated ATF4/CHOP apoptosis, and represents a promising lead compound for further development as a systemic anti-TNBC agent through formulation optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang 110001, China.
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. Electronic address: zhanglanx_9@126.com.
- Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address: wma@cmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Southwest Jiaotong University
Zitieren
APA
Song, Y., Yuan, Z., Li, Z., Huang, Y., Lu, Y., Yang, Q., Wang, Y., Zhang, L., & Ma, W. (2026). Repurposing butoconazole as a GRP78 substrate-binding domain (SBD) inhibitor to induce endoplasmic reticulum stress–mediated apoptosis in triple-negative breast cancer. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110447
Vancouver
Song Y, Yuan Z, Li Z, Huang Y, Lu Y, Yang Q, et al. Repurposing butoconazole as a GRP78 substrate-binding domain (SBD) inhibitor to induce endoplasmic reticulum stress–mediated apoptosis in triple-negative breast cancer. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110447
BibTeX
@article{Song2026,
author = {Song, Yaowen and Yuan, Ziyue and Li, Zhijia and Huang, Yunli and Lu, Yingying and Yang, Qianqian and Wang, Yan and Zhang, Lan and Ma, Wei},
title = {Repurposing butoconazole as a GRP78 substrate-binding domain (SBD) inhibitor to induce endoplasmic reticulum stress–mediated apoptosis in triple-negative breast cancer},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110447}
}
EUVIMED